Microbot Medical (Germany) Market Value
| CY9D Stock | EUR 0.92 0.01 1.08% |
| Symbol | Microbot |
Microbot Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Microbot Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Microbot Medical.
| 08/31/2024 |
| 11/29/2024 |
If you would invest 0.00 in Microbot Medical on August 31, 2024 and sell it all today you would earn a total of 0.00 from holding Microbot Medical or generate 0.0% return on investment in Microbot Medical over 90 days. Microbot Medical is related to or competes with SEI INVESTMENTS, Aedas Homes, Tri Pointe, M/I Homes, HK Electric, SLR Investment, and Gladstone Investment. Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted ... More
Microbot Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Microbot Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Microbot Medical upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.94 | |||
| Information Ratio | 0.0518 | |||
| Maximum Drawdown | 21.28 | |||
| Value At Risk | (6.10) | |||
| Potential Upside | 8.22 |
Microbot Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Microbot Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Microbot Medical's standard deviation. In reality, there are many statistical measures that can use Microbot Medical historical prices to predict the future Microbot Medical's volatility.| Risk Adjusted Performance | 0.0717 | |||
| Jensen Alpha | 0.3791 | |||
| Total Risk Alpha | (0.28) | |||
| Sortino Ratio | 0.0525 | |||
| Treynor Ratio | (0.66) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Microbot Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Microbot Medical Backtested Returns
Microbot Medical appears to be extremely dangerous, given 3 months investment horizon. Microbot Medical has Sharpe Ratio of 0.0831, which conveys that the firm had a 0.0831% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Microbot Medical, which you can use to evaluate the volatility of the firm. Please exercise Microbot Medical's Mean Deviation of 2.96, risk adjusted performance of 0.0717, and Downside Deviation of 3.94 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Microbot Medical holds a performance score of 6. The company secures a Beta (Market Risk) of -0.49, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Microbot Medical are expected to decrease at a much lower rate. During the bear market, Microbot Medical is likely to outperform the market. Please check Microbot Medical's downside deviation, information ratio, and the relationship between the semi deviation and coefficient of variation , to make a quick decision on whether Microbot Medical's current price movements will revert.
Auto-correlation | 0.07 |
Virtually no predictability
Microbot Medical has virtually no predictability. Overlapping area represents the amount of predictability between Microbot Medical time series from 31st of August 2024 to 15th of October 2024 and 15th of October 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Microbot Medical price movement. The serial correlation of 0.07 indicates that barely 7.0% of current Microbot Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.07 | |
| Spearman Rank Test | 0.18 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Microbot Medical lagged returns against current returns
Autocorrelation, which is Microbot Medical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Microbot Medical's stock expected returns. We can calculate the autocorrelation of Microbot Medical returns to help us make a trade decision. For example, suppose you find that Microbot Medical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Microbot Medical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Microbot Medical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Microbot Medical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Microbot Medical stock over time.
Current vs Lagged Prices |
| Timeline |
Microbot Medical Lagged Returns
When evaluating Microbot Medical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Microbot Medical stock have on its future price. Microbot Medical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Microbot Medical autocorrelation shows the relationship between Microbot Medical stock current value and its past values and can show if there is a momentum factor associated with investing in Microbot Medical.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Microbot Stock
When determining whether Microbot Medical is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Microbot Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Microbot Medical Stock. Highlighted below are key reports to facilitate an investment decision about Microbot Medical Stock:Check out Microbot Medical Correlation, Microbot Medical Volatility and Microbot Medical Alpha and Beta module to complement your research on Microbot Medical. For more detail on how to invest in Microbot Stock please use our How to Invest in Microbot Medical guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Microbot Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.